AbbVie
ABBV
#25
Rank
NZ$620.88 B
Marketcap
$350.99
Share price
-0.77%
Change (1 day)
15.95%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total assets

Total assets on the balance sheet as of December 2024 : NZ$233.00 Billion

According to AbbVie's latest financial reports the company's total assets are NZ$233.00 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

AbbVie - Total assets on balance sheet (from 2011 to 2024)

Total assets by year

Year Total assets Change
2024-12-31NZ$239.65 B12.51%
2023-12-31NZ$213.01 B-2.57%
2022-12-31NZ$218.62 B1.91%
2021-12-31NZ$214.52 B2.8%
2020-12-31NZ$208.67 B57.7%
2019-12-31NZ$132.32 B49.54%
2018-12-31NZ$88.48 B-11.22%
2017-12-31NZ$99.67 B4.45%
2016-12-31NZ$95.42 B23.11%
2015-12-31NZ$77.51 B120.74%
2014-12-31NZ$35.11 B-1.17%
2013-12-31NZ$35.53 B8.22%
2012-12-31NZ$32.83 B31.26%
2011-12-31NZ$25.01 B-8.7%
2010-12-31NZ$27.39 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
NZ$367.87 B 57.88%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$159.63 B-31.49%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$135.69 B-41.76%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$158.32 B-32.05%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$101.70 B-56.35%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$48.35 B-79.25%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$128.63 B-44.79%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$179.34 B-23.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$6.41 B-97.25%๐Ÿ‡บ๐Ÿ‡ธ USA